Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIANA: Dotinurad in Hyperuricemia with Hypertension
jRCTs021210013Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dotinurad in hyperuricemia and hypertension (HTN), sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoint: Primary: Rate of change in serum uric acid levels from Week 0 to Week 24. Started Jun 2021; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemiahypertension (HTN)
Beyond the preview
Go deeper on jRCTs021210013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021210013.